Pain and swelling, suffering and love: the NGF storys.
Mechanisms of alpha-synuclein toxicity in Parkinson's disease.
Epigenetic reprogramming in mammalian development.
Neural vulnerability mechanisms underlying stimulant addiction.
Cognitive biomarkers for detecting dementia.
Neurological changes in early stage Huntington's disease.
Information efficient communication.
Misfolding of proteins with polyglutamine expansion.
Early onset depressions: Can neuroscience aid clinical decision making?
Action decisions in health and Parkinson's disease.
Restoring executive control in drug addiction through the disruption on memories.
Complex brain networks, cognition and schizophrenia.
Multiple sclerosis, depleting lymphocytes and autoimmunity.
Mechanism-based therapy of stroke.
Human obesity: a heritable neurobehavioural disorder.
A multimodal approach to the assessment of impaired consciousness.
Why canine patients provide an important 'missing link' in spinal cord injury.
Can we ever really repair the brain in Parkinson's disease with cells.
Registration is open
Symposium organised by Professor Alastair Compston, Dr. Hannah Critchlow, Professor Peter Jones and Professor Trevor Robbins for Cambridge Neuroscience. Please contact cambridgeneuroscience@googlemail.com for all meeting enquiries.